Skip to main content
SpringerLink
Log in

The Evolving Landscape of Potency Assays

  • Chapter
  • First Online:
Potency Assays for Advanced Stem Cell Therapy Medicinal Products

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 1420))

Abstract

There is a “goldilocks” aspect to potency assays. On the one hand, a comprehensive evaluation of the cell product with detailed quantitative measurement of the critical quality attribute/s of the desired biological activity is required. On the other hand, the potency assay benefits from simplification and lean approaches that avoid unnecessary complication and enhance robustness, to provide a reproducible and scalable product. There is a need to balance insightful knowledge of complex biological healing processes with straightforward manufacture of an advanced therapeutic medicinal product (ATMP) that can be administered in a trustworthy cost-effective manner. While earlier chapters within this book have highlighted numerous challenges facing the potency assay conundrum, this chapter offers a forward-looking perspective regarding the many recent advances concerning acellular products, cryopreservation, induced MSC, cell priming, nanotechnology, 3D culture, regulatory guidelines and evolving institutional roles, that are likely to facilitate potency assay development in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Aguado T, Gutiérrez FJ, Aix E, Schneider RP, Giovinazzo G, Blasco MA, Flores I (2017) Telomere length defines the cardiomyocyte differentiation potency of mouse induced pluripotent stem cells. Stem Cells 35:362–373

    Article  CAS  PubMed  Google Scholar 

  2. Allsopp R (2012) Telomere length and iPSC re-programming: survival of the longest. Cell Res 22:614–615

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Amărandi RM, Becheru DF, Vlăsceanu GM, Ioniță M, Burns JS (2018) Advantages of graphene biosensors for human stem cell therapy potency assays. Biomed Res Int 2018:1676851

    Article  PubMed  PubMed Central  Google Scholar 

  4. Antwi-Baffour SS (2015) Molecular characterisation of plasma membrane-derived vesicles. J Biomed Sci 22:68

    Article  PubMed  PubMed Central  Google Scholar 

  5. Baglio SR, Pegtel DM, Baldini N (2012) Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy. Front Physiol 3:359

    Article  PubMed  PubMed Central  Google Scholar 

  6. Bahsoun S, Brown MJ, Coopman K, Akam EC (2022) Cryopreservation of human bone marrow derived mesenchymal stem cells at high concentration is feasible. Biopreserv Biobank. https://doi.org/10.1089/bio.2022.0017

  7. Bang OY, Kim JE (2022) Stem cell-derived extracellular vesicle therapy for acute brain insults and neurodegenerative diseases. BMB Rep 55:20–29

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Barlian A, Vanya K (2022) Nanotopography in directing osteogenic differentiation of mesenchymal stem cells: potency and future perspective. Future Sci OA 8:FSO765

    Article  CAS  PubMed  Google Scholar 

  9. Bazzan E, Tinè M, Casara A, Biondini D, Semenzato U, Cocconcelli E, Balestro E, Damin M, Radu CM, Turato G, Baraldo S, Simioni P, Spagnolo P, Saetta M, Cosio MG (2021) Critical review of the evolution of extracellular vesicles’ knowledge: from 1946 to today. Int J Mol Sci 22:6417

    Article  PubMed  PubMed Central  Google Scholar 

  10. Benson E, Betson F, Fuller BJ, Harding K, Kofanova O (2013) Translating cryobiology principles into trans-disciplinary storage guidelines for biorepositories and biobanks: a concept paper. Cryo Letters 34:277–312

    CAS  PubMed  Google Scholar 

  11. Bersenev A, Gustafson MP, Hanley PJ (2022) ISCT survey on hospital practices to support externally manufactured investigational cell-gene therapy products. Cytotherapy 24:27–31

    Article  CAS  PubMed  Google Scholar 

  12. Bhat R, Bissell MJ (2014) Of plasticity and specificity: dialectics of the microenvironment and macroenvironment and the organ phenotype. Wiley Interdiscip Rev Dev Biol 3:147–163

    Article  CAS  PubMed  Google Scholar 

  13. Bi Y, Qiao X, Liu Q, Song S, Zhu K, Qiu X, Zhang X, Jia C, Wang H, Yang Z, Zhang Y, Ji G (2022) Systemic proteomics and miRNA profile analysis of exosomes derived from human pluripotent stem cells. Stem Cell Res Ther 13:449

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Bissell MJ, Hines WC (2011) Why don’t we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med 17:320–329

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Bowles AC, Kouroupis D, Willman MA, Perucca Orfei C, Agarwal A, Correa D (2020) Signature quality attributes of CD146+ mesenchymal stem/stromal cells correlate with high therapeutic and secretory potency. Stem Cells 38:1034–1049

    Article  CAS  PubMed  Google Scholar 

  16. Braga CL, da Silva LR, Santos RT, de Carvalho LRP, Mandacaru SC, de Oliveira Trugilho MR, Rocco PRM, Cruz FF, Silva PL (2022) Proteomics profile of mesenchymal stromal cells and extracellular vesicles in normoxic and hypoxic conditions. Cytotherapy 24:1211–1224. S1465-3249(22)00783

    Article  CAS  PubMed  Google Scholar 

  17. Calcat-I-Cervera S, Sanz-Nogués C, O’Brien T (2021) When origin matters: properties of mesenchymal stromal cells from different sources for clinical translation in kidney disease. Front Med (Lausanne) 8:728496

    Article  PubMed  PubMed Central  Google Scholar 

  18. Canali C, Heiskanen A, Muhammad HB, Høyum P, Pettersen FJ, Hemmingsen M, Wolff A, Dufva M, Martinsen ØG, Emnéus J (2015) Bioimpedance monitoring of 3D cell culturing—complementary electrode configurations for enhanced spatial sensitivity. Biosens Bioelectron 63:72–79

    Article  CAS  PubMed  Google Scholar 

  19. Cao Q, Huang C, Chen XM, Pollock CA (2022) Mesenchymal stem cell-derived exosomes: toward cell-free therapeutic strategies in chronic kidney disease. Front Med (Lausanne) 9:816656

    Article  PubMed  Google Scholar 

  20. Capelli C, Frigerio S, Lisini D, Nava S, Gaipa G, Belotti D, Cabiati B, Budelli S, Lazzari L, Bagnarino J, Tanzi M, Comoli P, Perico N, Introna M, Golay J (2022) A comprehensive report of long-term stability data for a range ATMPs: a need to develop guidelines for safe and harmonized stability studies. Cytotherapy 24:544–556

    Article  CAS  PubMed  Google Scholar 

  21. Carthew J, Taylor JBJ, Garcia-Cruz MR, Kiaie N, Voelcker NH, Cadarso VJ, Frith JE (2022) The bumpy road to stem cell therapies: rational design of surface topographies to dictate stem cell mechanotransduction and fate. ACS Appl Mater Interfaces. https://doi.org/10.1021/acsami.1c22109

  22. Castella M, Caballero-Baños M, Ortiz-Maldonado V, González-Navarro EA, Suñé G, Antoñana-Vidósola A, Boronat A, Marzal B, Millán L, Martín-Antonio B, Cid J, Lozano M, García E, Tabera J, Trias E, Perpiña U, Canals JM, Baumann T, Benítez-Ribas D, Campo E, Yagüe J, Urbano-Ispizua Á, Rives S, Delgado J, Juan M (2020) Point-of-care CAR T-cell production (ARI-0001) using a closed semi-automatic bioreactor: experience from an academic phase I clinical trial. Front Immunol 11:482

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Chaudhuri O, Cooper-White J, Janmey PA, Mooney DJ, Shenoy VB (2020) Effects of extracellular matrix viscoelasticity on cellular behaviour. Nature 584:535–546

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Cheng J, Mao X, Chen C, Long X, Chen L, Zhou J, Zhu L (2022) Monitoring CAR19 T cell population by flow cytometry and its consistency with ddPCR. Cytometry A 103:16–26

    Article  PubMed  PubMed Central  Google Scholar 

  25. Cherian DS, Bhuvan T, Meagher L, Heng TSP (2020) Biological considerations in scaling up therapeutic cell manufacturing. Front Pharmacol 11:654

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Cheung HH, Liu X, Canterel-Thouennon L, Li L, Edmonson C, Rennert OM (2014) Telomerase protects Werner syndrome lineage-specific stem cells from premature aging. Stem Cell Rep 2:534–546

    Article  CAS  Google Scholar 

  27. Choudhery MS, Mahmood R, Harris DT, Ahmad FJ (2022) Minimum criteria for defining induced mesenchymal stem cells. Cell Biol Int 46:986–989

    Article  CAS  PubMed  Google Scholar 

  28. Chowdhury N (2010) Regulation of nanomedicines in the EU: distilling lessons from the pediatric and the advanced therapy medicinal products approaches. Nanomedicine (Lond) 5:135–142

    Article  PubMed  Google Scholar 

  29. Christy BA, Herzig MC, Delavan CP, Abaasah I, Cantu C, Salgado C, Lovelace S, Garcia L, Jensen K, Montgomery R, Cap AP, Bynum JA (2020) Use of multiple potency assays to evaluate human mesenchymal stromal cells. J Trauma Acute Care Surg 89:S109–S117

    Article  CAS  PubMed  Google Scholar 

  30. Costela-Ruiz VJ, Melguizo-Rodríguez L, Bellotti C, Illescas-Montes R, Stanco D, Arciola CR, Lucarelli E (2022) Different sources of mesenchymal stem cells for tissue regeneration: a guide to identifying the most favorable one in orthopedics and dentistry applications. Int J Mol Sci 23:6356

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Cottle C, Porter AP, Lipat A, Turner-Lyles C, Nguyen J, Moll G, Chinnadurai R (2022) Impact of cryopreservation and freeze-thawing on therapeutic properties of mesenchymal stromal/stem cells and other common cellular therapeutics. Curr Stem Cell Rep 8:72–92

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Cuende N, Ciccocioppo R, Forte M, Galipeau J, Ikonomou L, Levine BL, Srivastava A, Zettler PJ (2022) Patient access to and ethical considerations of the application of the European Union hospital exemption rule for advanced therapy medicinal products. Cytotherapy 24:686–690

    Article  PubMed  Google Scholar 

  33. Czapla J, Matuszczak S, Kulik K, Wiśniewska E, Pilny E, Jarosz-Biej M, Smolarczyk R, Sirek T, Zembala MO, Zembala M, Szala S, Cichoń T (2019) The effect of culture media on large-scale expansion and characteristic of adipose tissue-derived mesenchymal stromal cells. Stem Cell Res Ther 10:235

    Article  PubMed  PubMed Central  Google Scholar 

  34. Dapkute D, Pleckaitis M, Bulotiene D, Daunoravicius D, Rotomskis R, Karabanovas V (2021) Hitchhiking nanoparticles: mesenchymal stem cell-mediated delivery of theranostic nanoparticles. ACS Appl Mater Interfaces 13:43937–43951

    Article  CAS  PubMed  Google Scholar 

  35. Dave C, Mei SHJ, McRae A, Hum C, Sullivan KJ, Champagne J, Ramsay T, McIntyre L (2022) Comparison of freshly cultured versus cryopreserved mesenchymal stem cells in animal models of inflammation: a pre-clinical systematic review. elife 11:e75053

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. de Wilde S, Veltrop-Duits L, Hoozemans-Strik M, Ras T, Blom-Veenman J, Guchelaar HJ, Zandvliet M, Meij P (2016) Hurdles in clinical implementation of academic advanced therapy medicinal products: a national evaluation. Cytotherapy 18:797–805

    Article  PubMed  Google Scholar 

  37. Delgado J, Roddie C, Schmitt M (2022) Point-of-care production of CAR-T cells. In: Kröger N, Gribben J, Chabannon C, Yakoub-Agha I, Einsele H (eds) The EBMT/EHA CAR-T cell handbook. Springer, Cham

    Google Scholar 

  38. DiStefano TJ, Vaso K, Danias G, Chionuma HN, Weiser JR, Iatridis JC (2022) Extracellular vesicles as an emerging treatment option for intervertebral disc degeneration: therapeutic potential, translational pathways, and regulatory considerations. Adv Healthc Mater 11:e2100596

    Article  PubMed  Google Scholar 

  39. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315–317

    Article  CAS  PubMed  Google Scholar 

  40. Domnina A, Ivanova J, Alekseenko L, Kozhukharova I, Borodkina A, Pugovkina N, Smirnova I, Lyublinskaya O, Fridlyanskaya I, Nikolsky N (2020) Three-dimensional compaction switches stress response programs and enhances therapeutic efficacy of endometrial mesenchymal stem/stromal cells. Front Cell Dev Biol 8:473

    Article  PubMed  PubMed Central  Google Scholar 

  41. Doron G, Temenoff JS (2021) Culture substrates for improved manufacture of mesenchymal stromal cell therapies. Adv Healthc Mater 10:e2100016

    Article  PubMed  Google Scholar 

  42. Dupuis V, Oltra E (2021) Methods to produce induced pluripotent stem cell-derived mesenchymal stem cells: mesenchymal stem cells from induced pluripotent stem cells. World J Stem Cells 13:1094–1111

    Article  PubMed  PubMed Central  Google Scholar 

  43. Eichholz KF, Woods I, Riffault M, Johnson GP, Corrigan M, Lowry MC, Shen N, Labour MN, Wynne K, O’Driscoll L, Hoey DA (2020) Human bone marrow stem/stromal cell osteogenesis is regulated via mechanically activated osteocyte-derived extracellular vesicles. Stem Cells Transl Med 9:1431–1447

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Farkas AM, Mariz S, Stoyanova-Beninska V, Celis P, Vamvakas S, Larsson K, Sepodes B (2017) Advanced therapy medicinal products for rare diseases: state of play of incentives supporting development in Europe. Front Med (Lausanne) 4:53

    Article  PubMed  Google Scholar 

  45. Fernández-Santos M, García-Arranz M, Andreu E, García-Hernández A, López-Parra M, Villarón E, Sepúlveda P, Fernández-Avilés F, García-Olmo D, Prosper F, Sánchez-Guijo F, Moraleda JM, Zapata A (2022) Optimization of mesenchymal stromal cell (MSC) manufacturing processes for a better therapeutic outcome. Front Immunol 13:918565

    Article  PubMed  PubMed Central  Google Scholar 

  46. Galipeau J, Krampera M, Leblanc K, Nolta JA, Phinney DG, Shi Y, Tarte K, Viswanathan S, Martin I (2021) Mesenchymal stromal cell variables influencing clinical potency: the impact of viability, fitness, route of administration and host predisposition. Cytotherapy 23:368–372

    Article  CAS  PubMed  Google Scholar 

  47. Gimona M, Brizzi MF, Choo ABH, Dominici M, Davidson SM, Grillari J, Hermann DM, Hill AF, de Kleijn D, Lai RC (2021) Critical considerations for the development of potency tests for therapeutic applications of mesenchymal stromal cell-derived small extracellular vesicles. Cytotherapy 23:373–380

    Article  CAS  PubMed  Google Scholar 

  48. Ginty P (2020) Advanced therapy regulation in the UK: what might the future hold post-Brexit. Cell Gene Ther Insights 6:1171–1178

    Article  Google Scholar 

  49. Giubilato E, Cazzagon V, Amorim MJB, Blosi M, Bouillard J, Bouwmeester H, Costa AL, Fadeel B, Fernandes TF, Fito C, Hauser M, Marcomini A, Nowack B, Pizzol L, Powell L, Prina-Mello A, Sarimveis H, Scott-Fordsmand JJ, Semenzin E, Stahlmecke B, Stone V, Vignes A, Wilkins T, Zabeo A, Tran L, Hristozov D (2020) Risk management framework for nano-biomaterials used in medical devices and advanced therapy medicinal products. Materials (Basel) 13:E4532

    Article  Google Scholar 

  50. Golinelli G, Mastrolia I, Aramini B, Masciale V, Pinelli M, Pacchioni L, Casari G, Dall’Ora M, Soares MBP, Damasceno PKF, Silva DN, Dominici M, Grisendi G (2020) Arming mesenchymal stromal/stem cells against cancer: has the time come. Front Pharmacol 11:529921

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Gronthos S, Graves SE, Ohta S, Simmons PJ (1994) The STRO-1+ fraction of adult human bone marrow contains the osteogenic precursors. Blood 84:4164–4173

    Article  CAS  PubMed  Google Scholar 

  52. Guedan S, Luu M, Ammar D, Barbao P, Bonini C, Bousso P, Buchholz CJ, Casucci M, De Angelis B, Donnadieu E, Espie D, Greco B, Groen R, Huppa JB, Kantari-Mimoun C, Laugel B, Mantock M, Markman JL, Morris E, Quintarelli C, Rade M, Reiche K, Rodriguez-Garcia A, Rodriguez-Madoz JR, Ruggiero E, Themeli M, Hudecek M, Marchiq I (2022) Time 2EVOLVE: predicting efficacy of engineered T-cells – how far is the bench from the bedside. J Immunother Cancer 10:e003487

    Article  PubMed  PubMed Central  Google Scholar 

  53. Gultian KA, Gandhi R, Sarin K, Sladkova-Faure M, Zimmer M, de Peppo GM, Vega SL (2022) Human induced mesenchymal stem cells display increased sensitivity to matrix stiffness. Sci Rep 12:8483

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Haeusner S, Herbst L, Bittorf P, Schwarz T, Henze C, Mauermann M, Ochs J, Schmitt R, Blache U, Wixmerten A, Miot S, Martin I, Pullig O (2021) From single batch to mass production-automated platform design concept for a phase II clinical trial tissue engineered cartilage product. Front Med (Lausanne) 8:712917

    Article  PubMed  Google Scholar 

  55. Haga CL, Boregowda SV, Booker CN, Krishnappa V, Strivelli J, Cappelli E, Phinney DG (2022) Mesenchymal stem/stromal cells from a transplanted, asymptomatic patient with Fanconi anemia exhibit an aging-like phenotype and dysregulated expression of genes implicated in hematopoiesis and myelodysplasia. Cytotherapy 25:362–368. S1465-3249(22)01023

    Article  PubMed  Google Scholar 

  56. Hao D, Lu L, Song H, Duan Y, Chen J, Carney R, Li JJ, Zhou P, Nolta J, Lam KS, Leach JK, Farmer DL, Panitch A, Wang A (2022) Engineered extracellular vesicles with high collagen-binding affinity present superior in situ retention and therapeutic efficacy in tissue repair. Theranostics 12:6021–6037

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Hauskeller C (2017) Can harmonized regulation overcome intra-European differences? Insights from a European Phase III stem cell trial. Regen Med 12:599–609

    Article  CAS  PubMed  Google Scholar 

  58. Hildebrandt MG, Kidholm K, Pedersen JE, Naghavi-Behzad M, Knudsen T, Krag A, Ryg J, Gerke O, Lassen AT, Ellingsen T, Ditzel HJ, Andersen V, Langhoff A, Nielsen G, Masud T, Münster A-MB, Kyvik K, Brixen K (2022) How to increase value and reduce waste in research: initial experiences of applying Lean thinking and visual management in research leadership. BMJ Open 12:e058179

    Article  PubMed  PubMed Central  Google Scholar 

  59. Hills A, Awigena-Cook J, Genenz K, Ostertag M, Butler S, Eggimann AV, Hubert A (2020) An assessment of the hospital exemption landscape across European Member States: regulatory frameworks, use and impact. Cytotherapy 22:772–779.e1

    Article  PubMed  Google Scholar 

  60. Hindson BJ, Ness KD, Masquelier DA et al (2011) High-throughput droplet digital PCR system for absolute quantitation of DNA copy number. Anal Chem 83:8604–8610

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Hodgkinson T, Tsimbouri PM, Llopis-Hernandez V, Campsie P, Scurr D, Childs PG, Phillips D, Donnelly S, Wells JA, O’Brien FJ, Salmeron-Sanchez M, Burgess K, Alexander M, Vassalli M, Oreffo ROC, Reid S, France DJ, Dalby MJ (2021) The use of nanovibration to discover specific and potent bioactive metabolites that stimulate osteogenic differentiation in mesenchymal stem cells. Sci Adv 7:eabb7921

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Hollmann J, Brecht J, Goetzke R, Franzen J, Selich A, Schmidt M, Eipel M, Ostrowska A, Hapala J, Fernandez-Rebollo E, Müller-Newen G, Rothe M, Eggermann T, Zenke M, Wagner W (2020) Genetic barcoding reveals clonal dominance in iPSC-derived mesenchymal stromal cells. Stem Cell Res Ther 11:105

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Hornberger K, Yu G, McKenna D, Hubel A (2019) Cryopreservation of hematopoietic stem cells: emerging assays, cryoprotectant agents, and technology to improve outcomes. Transfus Med Hemother 46:188–196

    Article  PubMed  PubMed Central  Google Scholar 

  64. Hort S, Herbst L, Bäckel N, Erkens F, Niessing B, Frye M, König N, Papantoniou I, Hudecek M, Jacobs JJL, Schmitt RH (2022) Toward rapid, widely available autologous CAR-T cell therapy – artificial intelligence and automation enabling the smart manufacturing hospital. Front Med (Lausanne) 9:913287

    Article  PubMed  Google Scholar 

  65. Hu X, Xia Z, Cai K (2022) Recent advances in 3D hydrogel culture systems for mesenchymal stem cell-based therapy and cell behavior regulation. J Mater Chem B 10:1486–1507

    Article  CAS  PubMed  Google Scholar 

  66. Hu Y, Zhou Y, Zhang M, Zhao H, Wei G, Ge W, Cui Q, Mu Q, Chen G, Han L, Guo T, Cui J, Jiang X, Zheng X, Yu S, Li X, Zhang X, Chen M, Li X, Gao M, Wang K, Zu C, Zhang H, He X, Wang Y, Wang D, Ren J, Huang H (2022) Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies: a phase I clinical study. Cell Res 32:995–1007

    Article  CAS  PubMed  Google Scholar 

  67. Iglesias-López C, Agustí A, Obach M, Vallano A (2019) Regulatory framework for advanced therapy medicinal products in Europe and United States. Front Pharmacol 10:921

    Article  PubMed  PubMed Central  Google Scholar 

  68. Iglesias-Lopez C, Obach M, Vallano A, Agustí A (2021) Comparison of regulatory pathways for the approval of advanced therapies in the European Union and the United States. Cytotherapy 23:261–274

    Article  CAS  PubMed  Google Scholar 

  69. Jalilian E, Massoumi H, Bigit B, Amin S, Katz EA, Guaiquil VH, Anwar KN, Hematti P, Rosenblatt MI, Djalilian AR (2022) Bone marrow mesenchymal stromal cells in a 3D system produce higher concentration of extracellular vesicles (EVs) with increased complexity and enhanced neuronal growth properties. Stem Cell Res Ther 13:425

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Jansen BJ, Gilissen C, Roelofs H, Schaap-Oziemlak A, Veltman JA, Raymakers RA, Jansen JH, Kögler G, Figdor CG, Torensma R, Adema GJ (2010) Functional differences between mesenchymal stem cell populations are reflected by their transcriptome. Stem Cells Dev 19:481–490

    Article  CAS  PubMed  Google Scholar 

  71. Jauković A, Abadjieva D, Trivanović D, Stoyanova E, Kostadinova M, Pashova S, Kestendjieva S, Kukolj T, Jeseta M, Kistanova E, Mourdjeva M (2020) Specificity of 3D MSC spheroids microenvironment: impact on MSC behavior and properties. Stem Cell Rev Rep 16:853–875

    Article  PubMed  Google Scholar 

  72. Jo S, Das S, Williams A, Chretien AS, Pagliardini T, Le Roy A, Fernandez JP, Le Clerre D, Jahangiri B, Chion-Sotinel I, Rozlan S, Dessez E, Gouble A, Dusséaux M, Galetto R, Duclert A, Marcenaro E, Devillier R, Olive D, Duchateau P, Poirot L, Valton J (2022) Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing. Nat Commun 13:3453

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Kadle RL, Abdou SA, Villarreal-Ponce AP, Soares MA, Sultan DL, David JA, Massie J, Rifkin WJ, Rabbani P, Ceradini DJ (2018) Microenvironmental cues enhance mesenchymal stem cell-mediated immunomodulation and regulatory T-cell expansion. PLoS One 13:e0193178

    Article  PubMed  PubMed Central  Google Scholar 

  74. Kaushal R, Jahan S, McGregor C, Pineault N (2022) Dimethyl sulfoxide-free cryopreservation solutions for hematopoietic stem cell grafts. Cytotherapy 24:272–281

    Article  CAS  PubMed  Google Scholar 

  75. Keating A (2012) Mesenchymal stromal cells: new directions. Cell Stem Cell 10:709–716

    Article  CAS  PubMed  Google Scholar 

  76. Kim J, Park J, Song S-Y, Kim E (2022) Advanced therapy medicinal products for autologous chondrocytes and comparison of regulatory systems in target countries. Regen Ther 20:126–137

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Klbik I, Čechová K, Maťko I, Lakota J, Šauša O (2022) On crystallization of water confined in liposomes and cryoprotective action of DMSO. RSC Adv 12:2300–2309

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Kohli N, Al-Delfi IRT, Snow M, Sakamoto T, Miyazaki T, Nakajima H, Uchida K, Johnson WEB (2019) CD271-selected mesenchymal stem cells from adipose tissue enhance cartilage repair and are less angiogenic than plastic adherent mesenchymal stem cells. Sci Rep 9:3194

    Article  PubMed  PubMed Central  Google Scholar 

  79. Koleva-Kolarova R, Buchanan J, Vellekoop H, Huygens S, Versteegh M, Mölken MR, Szilberhorn L, Zelei T, Nagy B, Wordsworth S, Tsiachristas A, HEcoPerMed C (2022) Financing and reimbursement models for personalised medicine: a systematic review to identify current models and future options. Appl Health Econ Health Policy 20:501–524

    Article  PubMed  PubMed Central  Google Scholar 

  80. Kouroupis D, Correa D (2021) Increased mesenchymal stem cell functionalization in three-dimensional manufacturing settings for enhanced therapeutic applications. Front Bioeng Biotechnol 9:621748

    Article  PubMed  PubMed Central  Google Scholar 

  81. Kumawat VS, Bandyopadhyay-Ghosh S, Ghosh SB (2022) An overview of translational research in bone graft biomaterials. J Biomater Sci Polym Ed:1–44

    Google Scholar 

  82. Kurauchi R, Kasai H, Ito T (2020) Characteristics of medical products comprising human cells, genes, or tissues developed in Japan and the European Union compared via public assessment reports. Front Bioeng Biotechnol 8:606606

    Article  PubMed  PubMed Central  Google Scholar 

  83. Kusuma GD, Li A, Zhu D, McDonald H, Inocencio IM, Chambers DC, Sinclair K, Fang H, Greening DW, Frith JE, Lim R (2022) Effect of 2D and 3D culture microenvironments on mesenchymal stem cell-derived extracellular vesicles potencies. Front Cell Dev Biol 10:819726

    Article  PubMed  PubMed Central  Google Scholar 

  84. Lalu MM, Mazzarello S, Zlepnig J, Dong YYR, Montroy J, McIntyre L, Devereaux PJ, Stewart DJ, David Mazer C, Barron CC, McIsaac DI, Fergusson DA (2018) Safety and efficacy of adult stem cell therapy for acute myocardial infarction and ischemic heart failure (SafeCell Heart): a systematic review and meta-analysis. Stem Cells Transl Med 7:857–866

    Article  PubMed  PubMed Central  Google Scholar 

  85. Lalu MM, McIntyre L, Pugliese C, Fergusson D, Winston BW, Marshall JC, Granton J, Stewart DJ, Canadian CCTG (2012) Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. PLoS One 7:e47559

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Lee HR, Yang SJ, Choi HK, Kim JA, Oh IH (2021) The chromatin remodeling complex CHD1 regulates the primitive state of mesenchymal stromal cells to control their stem cell supporting activity. Stem Cells Dev 30:363–373

    Article  CAS  PubMed  Google Scholar 

  87. Lee S, Kim S, Kim H, Baek EJ, Jin H, Kim J, Kim HO (2008) Post-thaw viable CD34(+) cell count is a valuable predictor of haematopoietic stem cell engraftment in autologous peripheral blood stem cell transplantation. Vox Sang 94:146–152

    CAS  PubMed  Google Scholar 

  88. Leijten J, Chai YC, Papantoniou I, Geris L, Schrooten J, Luyten FP (2015) Cell based advanced therapeutic medicinal products for bone repair: keep it simple. Adv Drug Deliv Rev 84:30–44

    Article  CAS  PubMed  Google Scholar 

  89. Levy O, Kuai R, Siren EMJ, Bhere D, Milton Y, Nissar N, De Biasio M, Heinelt M, Reeve B, Abdi R, Alturki M, Fallatah M, Almalik A, Alhasan AH, Shah K, Karp JM (2020) Shattering barriers toward clinically meaningful MSC therapies. Sci Adv 6:eaba6884

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. Li C, Zhao H, Cheng L, Wang B (2021) Allogeneic vs. autologous mesenchymal stem/stromal cells in their medication practice. Cell Biosci 11:187

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  91. Lin H, Sohn J, Shen H, Langhans MT, Tuan RS (2019) Bone marrow mesenchymal stem cells: aging and tissue engineering applications to enhance bone healing. Biomaterials 203:96–110

    Article  CAS  PubMed  Google Scholar 

  92. Lindskog U, Lundgren B, Billig D, Lindner E (1987) Alternatives for harvesting cells grown on microcarriers: effects on subsequent attachment and growth. Dev Biol Stand 66:307–313

    CAS  PubMed  Google Scholar 

  93. Linkova DD, Rubtsova YP, Egorikhina MN (2022) Cryostorage of mesenchymal stem cells and biomedical cell-based products. Cell 11:2691

    Article  CAS  Google Scholar 

  94. López-Cantillo G, Urueña C, Camacho BA, Ramírez-Segura C (2022) CAR-T cell performance: how to improve their persistence. Front Immunol 13:878209

    Article  PubMed  PubMed Central  Google Scholar 

  95. Lopez-Navas L, Torrents S, Sánchez-Pernaute R, Vives J (2022) Compliance in non-clinical development of cell-, gene-, and tissue-based medicines: good practice for better therapies. Stem Cells Transl Med 11:805–813

    Article  PubMed  PubMed Central  Google Scholar 

  96. Lu A, Liu H, Shi R, Cai Y, Ma J, Shao L, Rong V, Gkitsas N, Lei H, Highfill SL, Panch S, Stroncek DF, Jin P (2020) Application of droplet digital PCR for the detection of vector copy number in clinical CAR/TCR T cell products. J Transl Med 18:191

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Lundh S, Maji S, Melenhorst JJ (2020) Next-generation CAR T cells to overcome current drawbacks. Int J Hematol 114:532–543

    Article  PubMed  Google Scholar 

  98. Luo Z, Yao X, Li M, Fang D, Fei Y, Cheng Z, Xu Y, Zhu B (2022) Modulating tumor physical microenvironment for fueling CAR-T cell therapy. Adv Drug Deliv Rev 185:114301

    Article  CAS  PubMed  Google Scholar 

  99. MacDonald AF, Trotter RD, Griffin CD, Bow AJ, Newby SD, King WJ, Amelse LL, Masi TJ, Bourdo SE, Dhar MS (2021) Genetic profiling of human bone marrow and adipose tissue-derived mesenchymal stem cells reveals differences in osteogenic signaling mediated by graphene. J Nanobiotechnol 19:285

    Article  CAS  Google Scholar 

  100. Malvicini R, Santa-Cruz D, De Lazzari G, Tolomeo AM, Sanmartin C, Muraca M, Yannarelli G, Pacienza N (2022) Macrophage bioassay standardization to assess the anti-inflammatory activity of mesenchymal stromal cell-derived small extracellular vesicles. Cytotherapy 24:999–1012

    Article  CAS  PubMed  Google Scholar 

  101. Marks PW, Witten CM, Califf RM (2017) Clarifying stem-cell therapy’s benefits and risks. N Engl J Med 376:1007–1009

    Article  PubMed  Google Scholar 

  102. Marple AH, Bonifant CL, Shah NN (2020) Improving CAR T-cells: the next generation. Semin Hematol 57:115–121

    Article  PubMed  Google Scholar 

  103. McGarvey SS, Ferreyros M, Kogut I, Bilousova G (2022) Differentiating induced pluripotent stem cells toward mesenchymal stem/stromal cells. Methods Mol Biol 2549:153–167

    Article  CAS  PubMed  Google Scholar 

  104. Méndez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, Lira SA, Scadden DT, Ma’ayan A, Enikolopov GN, Frenette PS (2010) Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466:829–834

    Article  PubMed  PubMed Central  Google Scholar 

  105. Mendicino M, Bailey AM, Wonnacott K, Puri RK, Bauer SR (2014) MSC-based product characterization for clinical trials: an FDA perspective. Cell Stem Cell 14:141–145

    Article  CAS  PubMed  Google Scholar 

  106. Meng HF, Jin J, Wang H, Wang LS, Wu CT (2022) Recent advances in the therapeutic efficacy of hepatocyte growth factor gene-modified mesenchymal stem cells in multiple disease settings. J Cell Mol Med 26:4745–4755

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  107. Min Lim K, Kim S, Yeom J, Choi Y, Lee Y, An J, Gil M, Abdal Dayem A, Kim K, Kang GH, Kim A, Hong K, Kim K, Cho SG (2022) Advanced 3D dynamic culture system with transforming growth factor-β3 enhances production of potent extracellular vesicles with modified protein cargoes via upregulation of TGF-β signaling. J Adv Res. https://doi.org/10.1016/j.jare.2022.09.005. S2090-1232(22)00207

  108. Mohapatra S, Mirza MA, Hilles AR, Zakir F, Gomes AC, Ansari MJ, Iqbal Z, Mahmood S (2021) Biomedical application, patent repository, clinical trial and regulatory updates on hydrogel: an extensive review. Gels 7:207

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  109. Moll G, Ankrum JA, Olson SD, Nolta JA (2022) Improved MSC minimal criteria to maximize patient safety: a call to embrace tissue factor and hemocompatibility assessment of MSC products. Stem Cells Transl Med 11:2–13

    Article  PubMed  PubMed Central  Google Scholar 

  110. Morgenstern DA, Ahsan G, Brocklesby M, Ings S, Balsa C, Veys P, Brock P, Anderson J, Amrolia P, Goulden N, Cale CM, Watts MJ (2016) Post-thaw viability of cryopreserved peripheral blood stem cells (PBSC) does not guarantee functional activity: important implications for quality assurance of stem cell transplant programmes. Br J Haematol 174:942–951

    Article  CAS  PubMed  Google Scholar 

  111. Mousaei Ghasroldasht M, Seok J, Park HS, Liakath Ali FB, Al-Hendy A (2022) Stem cell therapy: from idea to clinical practice. Int J Mol Sci 23:2850

    Article  PubMed  PubMed Central  Google Scholar 

  112. Mueller K, Saha K (2021) Single cell technologies to dissect heterogenous immune cell therapy products. Curr Opin Biomed Eng 20:100343

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  113. Muñoz-Domínguez N, Carreras-Sánchez I, López-Fernández A, Vives J (2022) Optimisation of processing methods to improve success in the derivation of human multipotent mesenchymal stromal cells from cryopreserved umbilical cord tissue fragments. Cryobiology 108:34–41

    Article  PubMed  Google Scholar 

  114. Ofiteru AM, Becheru DF, Gharbia S, Balta C, Herman H, Mladin B, Ionita M, Hermenean A, Burns JS (2020) Qualifying osteogenic potency assay metrics for human multipotent stromal cells: TGF-β2 a telling eligible biomarker. Cell 9:E2559

    Article  Google Scholar 

  115. Ogle ME, Doron G, Levy MJ, Temenoff JS (2020) Hydrogel culture surface stiffness modulates mesenchymal stromal cell secretome and alters senescence. Tissue Eng Part A 26:1259–1271

    Article  CAS  PubMed  Google Scholar 

  116. Oikonomopoulos A, van Deen WK, Manansala AR, Lacey PN, Tomakili TA, Ziman A, Hommes DW (2015) Optimization of human mesenchymal stem cell manufacturing: the effects of animal/xeno-free media. Sci Rep 5:16570

    Article  PubMed  PubMed Central  Google Scholar 

  117. Oja S, Kaartinen T, Ahti M, Korhonen M, Laitinen A, Nystedt J (2019) The utilization of freezing steps in mesenchymal stromal cell (MSC) manufacturing: potential impact on quality and cell functionality attributes. Front Immunol 10:1627

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  118. Pal B, Das B (2017) In vitro culture of naïve human bone marrow mesenchymal stem cells: a stemness based approach. Front Cell Dev Biol 5:69

    Article  PubMed  PubMed Central  Google Scholar 

  119. Pang SHM, D’Rozario J, Mendonca S, Bhuvan T, Payne NL, Zheng D, Hisana A, Wallis G, Barugahare A, Powell D, Rautela J, Huntington ND, Dewson G, Huang DCS, Gray DHD, Heng TSP (2021) Mesenchymal stromal cell apoptosis is required for their therapeutic function. Nat Commun 12:6495

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  120. Papait A, Ragni E, Cargnoni A, Vertua E, Romele P, Masserdotti A, Perucca Orfei C, Signoroni PB, Magatti M, Silini AR, De Girolamo L, Parolini O (2022) Comparison of EV-free fraction, EVs, and total secretome of amniotic mesenchymal stromal cells for their immunomodulatory potential: a translational perspective. Front Immunol 13:960909

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  121. Papamatthaiou S, Estrela P, Moschou D (2021) Printable graphene BioFETs for DNA quantification in Lab-on-PCB microsystems. Sci Rep 11:9815

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  122. Parekkadan B, Milwid JM (2010) Mesenchymal stem cells as therapeutics. Annu Rev Biomed Eng 12:87–117

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  123. Pellegrini G, Lambiase A, Macaluso C, Pocobelli A, Deng S, Cavallini G, Esteki R, Rama P (2016) From discovery to approval of an advanced therapy medicinal product-containing stem cells, in the EU. Regen Med 11:407–420

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  124. Peltzer J, Lund K, Goriot ME, Grosbot M, Lataillade JJ, Mauduit P, Banzet S (2020) Interferon-γ and hypoxia priming have limited effect on the miRNA landscape of human mesenchymal stromal cells-derived extracellular vesicles. Front Cell Dev Biol 8:581436

    Article  PubMed  PubMed Central  Google Scholar 

  125. Peng H, Chelvarajan L, Donahue R, Gottipati A, Cahall CF, Davis KA, Tripathi H, Al-Darraji A, Elsawalhy E, Dobrozsi N, Srinivasan A, Levitan BM, Kong R, Gao E, Abdel-Latif A, Berron BJ (2021) Polymer cell surface coating enhances mesenchymal stem cell retention and cardiac protection. ACS Appl Bio Mater 4:1655–1667

    Article  CAS  PubMed  Google Scholar 

  126. Pittenger MF, Discher DE, Péault BM, Phinney DG, Hare JM, Caplan AI (2019) Mesenchymal stem cell perspective: cell biology to clinical progress. NPJ Regen Med 4:22

    Article  PubMed  PubMed Central  Google Scholar 

  127. Pizevska M, Kaeda J, Fritsche E, Elazaly H, Reinke P, Amini L (2022) Advanced therapy medicinal products’ translation in Europe: a developers’ perspective. Front Med 9:757647

    Article  Google Scholar 

  128. Pochopień M, Paterak E, Clay E, Janik J, Aballea S, Biernikiewicz M, Toumi M (2021) An overview of health technology assessments of gene therapies with the focus on cost-effectiveness models. J Mark Access Health Policy 9:2002006

    Article  PubMed  PubMed Central  Google Scholar 

  129. Pollock K, Samsonraj RM, Dudakovic A, Thaler R, Stumbras A, McKenna DH, Dosa PI, van Wijnen AJ, Hubel A (2017) Improved post-thaw function and epigenetic changes in mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions. Stem Cells Dev 26:828–842

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  130. Pollock K, Sumstad D, Kadidlo D, McKenna DH, Hubel A (2015) Clinical mesenchymal stromal cell products undergo functional changes in response to freezing. Cytotherapy 17:38–45

    Article  PubMed  Google Scholar 

  131. Pratt CB, Alexander M (2022) Importance of CAR-T cell therapy monitoring using high-throughput assays. Drug Discov Today 27:103310

    Article  CAS  PubMed  Google Scholar 

  132. Priesner C, Hildebrandt M (2022) Advanced therapy medicinal products and the changing role of academia. Transfus Med Hemother 49(3):158–162

    Article  PubMed  PubMed Central  Google Scholar 

  133. Pybus LP, Kalsi D, Matthews JT, Hawke E, Barber N, Richer R, Young A, Saunders FL (2022) Coupling picodroplet microfluidics with plate imaging for the rapid creation of biomanufacturing suitable cell lines with high probability and improved multi-step assurance of monoclonality. Biotechnol J 17:e2100357

    Article  PubMed  Google Scholar 

  134. Quirici N, Soligo D, Bossolasco P, Servida F, Lumini C, Deliliers GL (2002) Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol 30:783–791

    Article  CAS  PubMed  Google Scholar 

  135. Rana N, Suliman S, Al-Sharabi N, Mustafa K (2022) Extracellular vesicles derived from primed mesenchymal stromal cells loaded on biphasic calcium phosphate biomaterial exhibit enhanced macrophage polarization. Cells 11(3):470

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  136. Ranga Rao S, Subbarayan R (2019) Passage-dependent expression of STRO-1 in human gingival mesenchymal stem cells. J Cell Biochem 120:2810–2815

    Article  CAS  PubMed  Google Scholar 

  137. Roddie C, Dias J, O’Reilly MA, Abbasian M, Cadinanos-Garai A, Vispute K, Bosshard-Carter L, Mitsikakou M, Mehra V, Roddy H, Hartley JA, Spanswick V, Lowe H, Popova B, Clifton-Hadley L, Wheeler G, Olejnik J, Bloor A, Irvine D, Wood L, Marzolini MAV, Domning S, Farzaneh F, Lowdell MW, Linch DC, Pule MA, Peggs KS (2021) Durable responses and low toxicity after fast off-rate CD19 chimeric antigen receptor-T therapy in adults with relapsed or refractory B-cell acute lymphoblastic leukemia. J Clin Oncol 39:3352–3363

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  138. Rodrigues CA, Fernandes TG, Diogo MM, da Silva CL, Cabral JM (2011) Stem cell cultivation in bioreactors. Biotechnol Adv 29:815–829

    Article  CAS  PubMed  Google Scholar 

  139. Rosell-Valle C, Antúnez C, Campos F, Gallot N, García-Arranz M, García-Olmo D, Gutierrez R, Hernán R, Herrera C, Jiménez R, Leyva-Fernández L, Maldonado-Sanchez R, Muñoz-Fernández R, Nogueras S, Ortiz L, Piudo I, Ranchal I, Rodríguez-Acosta A, Segovia C, Fernández-Muñoz B (2021) Evaluation of the effectiveness of a new cryopreservation system based on a two-compartment vial for the cryopreservation of cell therapy products. Cytotherapy 23:740–753

    Article  CAS  PubMed  Google Scholar 

  140. Rosová I, Dao M, Capoccia B, Link D, Nolta JA (2008) Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 26:2173–2182

    Article  PubMed  Google Scholar 

  141. Ryan JM, Barry F, Murphy JM, Mahon BP (2007) Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin Exp Immunol 149:353–363

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  142. Sacchetti M, Rama P, Bruscolini A, Lambiase A (2018) Limbal stem cell transplantation: clinical results, limits, and perspectives. Stem Cells Int 2018:8086269

    Article  PubMed  PubMed Central  Google Scholar 

  143. Samsonraj RM, Raghunath M, Nurcombe V, Hui JH, van Wijnen AJ, Cool SM (2017) Concise review: multifaceted characterization of human mesenchymal stem cells for use in regenerative medicine. Stem Cells Transl Med 6:2173–2185

    Article  PubMed  PubMed Central  Google Scholar 

  144. Sanber K, Savani B, Jain T (2021) Graft-versus-host disease risk after chimeric antigen receptor T-cell therapy: the diametric opposition of T cells. Br J Haematol 195:660–668

    Article  CAS  PubMed  Google Scholar 

  145. Schneider RS, Vela AC, Williams EK, Martin KE, Lam WA, García AJ (2022) High-throughput on-chip human mesenchymal stromal cell potency prediction. Adv Healthc Mater 11:e2101995

    Article  PubMed  Google Scholar 

  146. Schubert ML, Berger C, Kunz A, Schmitt A, Badbaran A, Neuber B, Zeschke S, Wang L, Riecken K, Hückelhoven-Krauss A, Müller I, Müller-Tidow C, Dreger P, Kröger N, Ayuk FA, Schmitt M, Fehse B (2022) Comparison of single copy gene-based duplex quantitative PCR and digital droplet PCR for monitoring of expansion of CD19-directed CAR T cells in treated patients. Int J Oncol 60:48

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  147. Sebastião MJ, Serra M, Gomes-Alves P, Alves PM (2021) Stem cells characterization: OMICS reinforcing analytics. Curr Opin Biotechnol 71:175–181

    Article  PubMed  Google Scholar 

  148. Sepodes B, Mol P (2022) Editorial: insights in regulatory science 2021. Front Med (Lausanne) 9:1033558

    Article  PubMed  Google Scholar 

  149. Shekari F, Nazari A, Assar Kashani S, Hajizadeh-Saffar E, Lim R, Baharvand H (2021) Pre-clinical investigation of mesenchymal stromal cell-derived extracellular vesicles: a systematic review. Cytotherapy 23:277–284

    Article  CAS  PubMed  Google Scholar 

  150. Shen JL, Huang YZ, Xu SX, Zheng PH, Yin WJ, Cen J, Gong LZ (2012) Effectiveness of human mesenchymal stem cells derived from bone marrow cryopreserved for 23-25 years. Cryobiology 64:167–175

    Article  CAS  PubMed  Google Scholar 

  151. Si X, Xiao L, Brown CE, Wang D (2022) Preclinical evaluation of CAR T cell function: in vitro and in vivo models. Int J Mol Sci 23:3154

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  152. Silva Couto P, Rotondi MC, Bersenev A, Hewitt CJ, Nienow AW, Verter F, Rafiq QA (2020) Expansion of human mesenchymal stem/stromal cells (hMSCs) in bioreactors using microcarriers: lessons learnt and what the future holds. Biotechnol Adv 45:107636

    Article  CAS  PubMed  Google Scholar 

  153. Simonsen JL, Rosada C, Serakinci N, Justesen J, Stenderup K, Rattan SI, Jensen TG, Kassem M (2002) Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol 20:592–596

    Article  CAS  PubMed  Google Scholar 

  154. Spitzhorn LS, Megges M, Wruck W, Rahman MS, Otte J, Degistirici Ö, Meisel R, Sorg RV, Oreffo ROC, Adjaye J (2019) Human iPSC-derived MSCs (iMSCs) from aged individuals acquire a rejuvenation signature. Stem Cell Res Ther 10:100

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  155. Spohn G, Witte AS, Kretschmer A, Seifried E, Schäfer R (2021) More human BM-MSC with similar subpopulation composition and functional characteristics can be produced with a GMP-compatible fabric filter system compared to density gradient technique. Front Cell Dev Biol 9:638798

    Article  PubMed  PubMed Central  Google Scholar 

  156. Srinivasan A, Sathiyanathan P, Yin L, Liu TM, Lam A, Ravikumar M, Smith RAA, Loh HP, Zhang Y, Ling L, Ng SK, Yang YS, Lezhava A, Hui J, Oh S, Cool SM (2022) Strategies to enhance immunomodulatory properties and reduce heterogeneity in mesenchymal stromal cells during ex vivo expansion. Cytotherapy 24:456–472

    Article  CAS  PubMed  Google Scholar 

  157. Srinivasan M, Thangaraj SR, Ramasubramanian K, Thangaraj PP, Ramasubramanian KV (2021) Exploring the current trends of artificial intelligence in stem cell therapy: a systematic review. Cureus 13:e20083

    PubMed  PubMed Central  Google Scholar 

  158. Starokozhko V, Kallio M, Kumlin Howell Å, Mäkinen Salmi A, Andrew-Nielsen G, Goldammer M, Burggraf M, Löbker W, Böhmer A, Agricola E, de Vries CS, Pasmooij AMG, Mol PGM, STARS C (2021) Strengthening regulatory science in academia: STARS, an EU initiative to bridge the translational gap. Drug Discov Today 26:283–288

    Article  PubMed  Google Scholar 

  159. Sugarman J, Barker R, Charo R (2019) A professional standard for informed consent for stem cell therapies. JAMA 322(17):1651–1652

    Article  PubMed  Google Scholar 

  160. Sung SE, Kang KK, Choi JH, Lee SJ, Kim K, Lim JH, Yang SY, Kim SK, Seo MS, Lee GW (2021) Comparisons of extracellular vesicles from human epidural fat-derived mesenchymal stem cells and fibroblast cells. Int J Mol Sci 22:2889

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  161. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861–872

    Article  CAS  PubMed  Google Scholar 

  162. Takeuchi S, Tsuchiya A, Iwasawa T, Nojiri S, Watanabe T, Ogawa M, Yoshida T, Fujiki K, Koui Y, Kido T, Yoshioka Y, Fujita M, Kikuta J, Itoh T, Takamura M, Shirahige K, Ishii M, Ochiya T, Miyajima A, Terai S (2021) Small extracellular vesicles derived from interferon-γ pre-conditioned mesenchymal stromal cells effectively treat liver fibrosis. NPJ Regen Med 6:19

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  163. Tang L, Mei Y, Shen Y, He S, Xiao Q, Yin Y, Xu Y, Shao J, Wang W, Cai Z (2021) Nanoparticle-mediated targeted drug delivery to remodel tumor microenvironment for cancer therapy. Int J Nanomedicine 16:5811–5829

    Article  PubMed  PubMed Central  Google Scholar 

  164. Tay LM, Wiraja C, Yeo DC, Wu Y, Yang Z, Chuah YJ, Lee EH, Kang Y, Xu C (2017) Noninvasive monitoring of three-dimensional chondrogenic constructs using molecular beacon nanosensors. Tissue Eng Part C Methods 23:12–20

    Article  CAS  PubMed  Google Scholar 

  165. Taylor SC, Laperriere G, Germain H (2017) Droplet Digital PCR versus qPCR for gene expression analysis with low abundant targets: from variable nonsense to publication quality data. Sci Rep 7:2409

    Article  PubMed  PubMed Central  Google Scholar 

  166. TerWee JA, Chin CL, Watrin S, Tello RF, Rieder NJ, Lowell JD, Latham-Timmons D (2011) Increased consistency and efficiency in routine potency testing by bioassay with direct use of cryopreserved (ready-to-plate) cells. J Immunol Methods 370:65–74

    Article  CAS  PubMed  Google Scholar 

  167. Thamm K, Möbus K, Towers R, Baertschi S, Wetzel R, Wobus M, Segeletz S (2022) A chemically defined biomimetic surface for enhanced isolation efficiency of high-quality human mesenchymal stromal cells under xenogeneic/serum-free conditions. Cytotherapy 24:1049–1059

    Article  CAS  PubMed  Google Scholar 

  168. Théry C, Witwer KW, Aikawa E et al (2018) Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles 7:1535750

    Article  PubMed  PubMed Central  Google Scholar 

  169. Tieu A, Lalu MM, Slobodian M, Gnyra C, Fergusson DA, Montroy J, Burger D, Stewart DJ, Allan DS (2020) An analysis of mesenchymal stem cell-derived extracellular vesicles for preclinical use. ACS Nano 14:9728–9743

    Article  CAS  PubMed  Google Scholar 

  170. Ting DSJ, Peh GSL, Adnan K, Mehta JS (2022) Translational and regulatory challenges of corneal endothelial cell therapy: a global perspective. Tissue Eng Part B Rev 28:52–62

    Article  CAS  PubMed  Google Scholar 

  171. Tormin A, Li O, Brune JC, Walsh S, Schütz B, Ehinger M, Ditzel N, Kassem M, Scheding S (2011) CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization. Blood 117:5067–5077

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  172. Trachana V, Petrakis S, Fotiadis Z, Siska EK, Balis V, Gonos ES, Kaloyianni M, Koliakos G (2017) Human mesenchymal stem cells with enhanced telomerase activity acquire resistance against oxidative stress-induced genomic damage. Cytotherapy 19:808–820

    Article  CAS  PubMed  Google Scholar 

  173. Tsai AC, Jeske R, Chen X, Yuan X, Li Y (2020) Influence of microenvironment on mesenchymal stem cell therapeutic potency: from planar culture to microcarriers. Front Bioeng Biotechnol 8:640

    Article  PubMed  PubMed Central  Google Scholar 

  174. Veronesi E, Murgia A, Caselli A, Grisendi G, Piccinno MS, Rasini V, Giordano R, Montemurro T, Bourin P, Sensebé L, Rojewski MT, Schrezenmeier H, Layrolle P, Ginebra MP, Panaitescu CB, Gómez-Barrena E, Catani F, Paolucci P, Burns JS, Dominici M (2014) Transportation conditions for prompt use of ex vivo expanded and freshly harvested clinical-grade bone marrow mesenchymal stromal/stem cells for bone regeneration. Tissue Eng Part C Methods 20:239–251

    Article  CAS  PubMed  Google Scholar 

  175. Vieira CP, McCarrel TM, Grant MB (2021) Novel methods to mobilize, isolate, and expand mesenchymal stem cells. Int J Mol Sci 22:5728

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  176. Vives J, Sòria MG, McGrath E, Magri M (2022) The quality management ecosystem in cell therapy in Catalonia (Spain): an opportunity for integrating standards and streamlining quality compliance. Cell 11:2112

    Article  Google Scholar 

  177. Vonk LA, van Dooremalen SFJ, Liv N, Klumperman J, Coffer PJ, Saris DBF, Lorenowicz MJ (2018) Mesenchymal stromal/stem cell-derived extracellular vesicles promote human cartilage regeneration in vitro. Theranostics 8:906–920

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  178. Vreman RA, Heikkinen I, Schuurman A, Sapede C, Garcia JL, Hedberg N, Athanasiou D, Grueger J, Leufkens HGM, Goettsch WG (2019) Unmet medical need: an introduction to definitions and stakeholder perceptions. Value Health 22:1275–1282

    Article  PubMed  Google Scholar 

  179. Wagner DL, Koehl U, Chmielewski M, Scheid C, Stripecke R (2022) Review: sustainable clinical development of CAR-T cells – switching from viral transduction towards CRISPR-Cas gene editing. Front Immunol 13:865424

    Article  PubMed  PubMed Central  Google Scholar 

  180. Wang J, Chen G, Chen ZM, Wang FP, Xia B (2022) Current strategies in biomaterial-based periosteum scaffolds to promote bone regeneration: a review. J Biomater Appl:8853282221135095

    Google Scholar 

  181. Watanabe Y, Fukuda T, Hayashi C, Nakao Y, Toyoda M, Kawakami K, Shinjo T, Iwashita M, Yamato H, Yotsumoto K, Taketomi T, Uchiumi T, Sanui T, Nishimura F (2022) Extracellular vesicles derived from GMSCs stimulated with TNF-α and IFN-α promote M2 macrophage polarization via enhanced CD73 and CD5L expression. Sci Rep 12:13344

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  182. Watt SM (2022) The long and winding road: homeostatic and disordered haematopoietic microenvironmental niches: a narrative review. Biomater Transl 3:31–54

    PubMed  PubMed Central  Google Scholar 

  183. Wechsler ME, Rao VV, Borelli AN, Anseth KS (2021) Engineering the MSC secretome: a hydrogel focused approach. Adv Healthc Mater 10:e2001948

    Article  PubMed  PubMed Central  Google Scholar 

  184. Werb Z, Sympson CJ, Alexander CM, Thomasset N, Lund LR, MacAuley A, Ashkenas J, Bissell MJ (1996) Extracellular matrix remodeling and the regulation of epithelial-stromal interactions during differentiation and involution. Kidney Int Suppl 54:S68–S74

    CAS  PubMed  PubMed Central  Google Scholar 

  185. Wiese DM, Wood CA, Braid LR (2022) From vial to vein: crucial gaps in mesenchymal stromal cell clinical trial reporting. Front Cell Dev Biol 10:867426

    Article  PubMed  PubMed Central  Google Scholar 

  186. Witwer KW, Goberdhan DC, O’Driscoll L, Théry C, Welsh JA, Blenkiron C, Buzás EI, Di Vizio D, Erdbrügger U, Falcón-Pérez JM, Fu QL, Hill AF, Lenassi M, Lötvall J, Nieuwland R, Ochiya T, Rome S, Sahoo S, Zheng L (2021) Updating MISEV: evolving the minimal requirements for studies of extracellular vesicles. J Extracell Vesicles 10:e12182

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  187. Witwer KW, Van Balkom BWM, Bruno S, Choo A, Dominici M, Gimona M, Hill AF, De Kleijn D, Koh M, Lai RC, Mitsialis SA, Ortiz LA, Rohde E, Asada T, Toh WS, Weiss DJ, Zheng L, Giebel B, Lim SK (2019) Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications. J Extracell Vesicles 8:1609206

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  188. Wruck W, Graffmann N, Spitzhorn LS, Adjaye J (2021) Human induced pluripotent stem cell-derived mesenchymal stem cells acquire rejuvenation and reduced heterogeneity. Front Cell Dev Biol 9:717772

    Article  PubMed  PubMed Central  Google Scholar 

  189. Wrzesinski K, Rogowska-Wrzesinska A, Kanlaya R, Borkowski K, Schwämmle V, Dai J, Joensen KE, Wojdyla K, Carvalho VB, Fey SJ (2014) The cultural divide: exponential growth in classical 2D and metabolic equilibrium in 3D environments. PLoS One 9:e106973

    Article  PubMed  PubMed Central  Google Scholar 

  190. Wu X, Schmidt-Wolf IGH (2022) An alternative source for allogeneic CAR T cells with a high safety profile. Front Immunol 13:913123

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  191. Xu D, Marchionni K, Hu Y, Zhang W, Sosic Z (2017) Quantitative analysis of a biopharmaceutical protein in cell culture samples using automated capillary electrophoresis (CE) western blot. J Pharm Biomed Anal 145:10–15

    Article  CAS  PubMed  Google Scholar 

  192. Yen BL, Liu KJ, Sytwu HK, Yen ML (2022) Clinical implications of differential functional capacity between tissue-specific human mesenchymal stromal/stem cells. FEBS J. https://doi.org/10.1111/febs.16438

  193. Yin JQ, Zhu J, Ankrum JA (2019) Manufacturing of primed mesenchymal stromal cells for therapy. Nat Biomed Eng 3:90–104

    Article  CAS  PubMed  Google Scholar 

  194. Yin Y, Boesteanu AC, Binder ZA, Xu C, Reid RA, Rodriguez JL, Cook DR, Thokala R, Blouch K, McGettigan-Croce B, Zhang L, Konradt C, Cogdill AP, Panjwani MK, Jiang S, Migliorini D, Dahmane N, Posey AD, June CH, Mason NJ, Lin Z, O’Rourke DM, Johnson LA (2018) Checkpoint blockade reverses anergy in IL-13Rα2 humanized scFv-based CAR T cells to treat murine and canine gliomas. Mol Ther Oncolytics 11:20–38

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  195. Yui H, Muto K, Yashiro Y, Watanabe S, Kiya Y, Kamisato A, Inoue Y, Yamagata Z (2022) Comparison of the 2021 International Society for Stem Cell Research (ISSCR) guidelines for “laboratory-based human stem cell research, embryo research, and related research activities” and the corresponding Japanese regulations. Regen Ther 21:46–51

    Article  PubMed  PubMed Central  Google Scholar 

  196. Zhai Q, Chen X, Fei D, Guo X, He X, Zhao W, Shi S, Gooding JJ, Jin F, Jin Y, Li B (2022) Nanorepairers rescue inflammation-induced mitochondrial dysfunction in mesenchymal stem cells. Adv Sci (Weinh) 9:e2103839

    Article  PubMed  Google Scholar 

  197. Zhang J, Chen M, Liao J, Chang C, Liu Y, Padhiar AA, Zhou Y, Zhou G (2021) Induced pluripotent stem cell-derived mesenchymal stem cells hold lower heterogeneity and great promise in biological research and clinical applications. Front Cell Dev Biol 9:716907

    PubMed  PubMed Central  Google Scholar 

  198. Zhuang Y, Jiang S, Yuan C, Lin K (2022) The potential therapeutic role of extracellular vesicles in osteoarthritis. Front Bioeng Biotechnol 10:1022368

    Article  PubMed  PubMed Central  Google Scholar 

  199. Zieliński PS, Gudeti PKR, Rikmanspoel T, Włodarczyk-Biegun MK (2023) 3D printing of bio-instructive materials: toward directing the cell. Bioact Mater 19:292–327

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Environmental and Prevention Sciences, University of Ferrara, Ferrara, Italy

    Jorge S. Burns

Authors
  1. Jorge S. Burns
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jorge S. Burns .

Editor information

Editors and Affiliations

  1. University of Ferrara, Ferrara, Italy

    Jorge S. Burns

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Burns, J.S. (2023). The Evolving Landscape of Potency Assays. In: Burns, J.S. (eds) Potency Assays for Advanced Stem Cell Therapy Medicinal Products. Advances in Experimental Medicine and Biology, vol 1420. Springer, Cham. https://doi.org/10.1007/978-3-031-30040-0_11

Download citation

Publish with us

Policies and ethics

Search

Navigation